---
$id: https://graph.org.ai/products/commodity/51361801
$type: Product
source: UNSPSC
code: "51361801"
title: "Dexmedetomidine"
class: "51361800"
classTitle: "Hypnotic azoles"
family: "51360000"
familyTitle: "Hypnotics"
segment: "51000000"
segmentTitle: "Pharmaceutical Products incl. Contraceptives and Vaccines"


---

# Dexmedetomidine

**UNSPSC Code**: 51361801
**Class**: [Hypnotic azoles](Hypnotic azoles.mdx)
**Family**: [Hypnotics](../Hypnotics.mdx)
**Segment**: [Pharmaceutical Products incl. Contraceptives and Vaccines](../../Pharmaceutical Products incl. Contraceptives and Vaccines.mdx)

This classification denotes an alpha-adrenergic agonist with the molecular formula C13H16N2, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier 67VB76HONO, chemically known as 1h-imidazole, 4-(1-(2,3-dimethylphenyl)ethyl)-, (r)- but generally known as dexmedetomidine, which bears US NIH Compound Identifier 60612. European Medicines Agency schedules Dexmedetomidine in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB07037MIG. The term DEXMEDETOMIDINE is an International Non-Proprietary Name or INN (see WHO INN reference publication, Volume 13 No. 3, 1999, List 42). World Health Organization schedules dexmedetomidine in its Anatomical Therapeutic Chemical (ATC) Classification. Most nations schedule dexmedetomidine under HS 29332990 and SITC 51573. As of Q4 2014, DEXMEDETOMIDINE remains the US FDA Preferred Term for this commodity. Dexmedetomidine bears US NLM identifiers UMLS ID C0113293 and NCI Concept Code C47479. SMILES: [NH]1C(C(C2C(C(CCC2)C)C)C)CNC1.

